Industries > Pharma > Nuclear Medicine Market Report 2021-2031

Nuclear Medicine Market Report 2021-2031

Forecasts by Type (Diagnostic (SPECT - Technetium, PET- F-18), by Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios

PAGES: 192
PRODUCT CODE: PHA0943

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0943 Categories: , Tag:

Nuclear Medicine/Radiopharmaceuticals Market-our new study reveals current trends, technological advancements, and predicted revenues

Where the Nuclear Medicine/Radiopharmaceuticals market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 190+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Nuclear Medicine/Radiopharmaceuticals market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

– In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors

– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players

– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Report Scope

Global Nuclear Medicine/Radiopharmaceuticals market 2021-2031 is segmented on the basis of Product, Application and Geography.

• Revenue and growth forecasts from 2021 to 2031 for the Global Nuclear Medicine/Radiopharmaceuticals Market by Product:

– Diagnostic Products
– Diagnostic Products
– TC-99m
– TL-201
– GA-67
– I-123
– Other SPECT products

– PET
– F-18
– SR-82/RB-82
– Other PET products

– Therapeutic Products
– Alpha emitters
– RA-223
– Other alpha emitters
– Beta emitters
– I-131
– Y-90
– SM-153
– Re-186
– Lu-117
– Other beta emitters

– Brachytherapy
– Cesium-131
– Iodine-125
– Palladium-103
– Iridium-192
– Other brachytherapy products

• Revenue and growth forecasts from 2021 to 2031 for the Global Nuclear Medicine/Radiopharmaceuticals Market by Application:

– Cardiology

– Neurology

– Oncology

–Thyroid

–Lymphoma

–Bone metastasis

– Endocrine tumor

• Revenue and growth forecasts from 2021 to 2031 for the Global Nuclear Medicine/Radiopharmaceuticals Market by Region:

– North America: US, Canada

– Europe: Germany, UK, Italy, France, Spain, Rest of Europe

– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific

– Latin America: Brazil, Mexico, and Rest of Latin America

– Middle East & Africa: GCC, South Africa, Rest of MEA

• Our study discusses the selected leading companies that are the major players in the Nuclear Medicine/Radiopharmaceuticals industry:

– Eckert & Ziegler

–Mallinckrodt

– Curium Pharma

– GE Healthcare

– Jubilant Pharma. LLC

– Bracco Imaging S.p.A

– Nordion (Canada) Inc.

– The Institute for Radioelements (IRE – IRE ELiT)

– Australian Nuclear Science & Technology Organization (ANSTO)

– NTP Radioisotopes SOC Ltd.

–Eczacibasi-Monrol

–Lantheus Medical Imaging, Inc.

How the Nuclear Medicine/Radiopharmaceuticals Market report helps you

In summary, our 190+ page report provides you with the following knowledge:
– Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.

– Revenue forecasts to 2031 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Nuclear Medicine/Radiopharmaceuticals market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

COVID 19 Impact & Recovery Analysis on the Market

Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.

The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.

Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the Nuclear Medicine market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Nuclear Medicine/Radiopharmaceuticals market and leading companies. You will find data, trends and predictions.

The Nuclear Medicine/Radiopharmaceuticals Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Nuclear Medicine/Radiopharmaceuticals industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Nuclear Medicine Market Report 2021-2031: Forecasts by Type (Diagnostic (SPECT – Technetium, PET- F-18), by Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Nuclear Medicine Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Nuclear Medicine Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Fill-Finish Manufacturing Market Report 2021-2031

Automation is a rising trend in the supply chain as a way to reduce time to market and enhance efficiency. Automation is appealing for a variety of reasons, the most important of which is that it reduces human contact and hence interference.

02 September 2021

READ

Visiongain Publishes Epilepsy Therapeutics Market Report 2021-2031

As governments in emerging countries are taking measures to improve healthcare, it is positively impacting the anti-epileptic drugs market growth.

24 August 2021

READ

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2021-2031

From a long-term perspective, the rapid growth of the mid-class economy will enhance the demand for OTC products in emerging economies such as China, India and Brazil.

24 August 2021

READ

Visiongain Publishes Bowel Management Systems Market Report 2021-2031

Growing female population with faecal incontinence to fuel bowel management systems market growth through 2031.

17 August 2021

READ

Categories